# Everstone

> Everstone is a VC fund in Singapore backing Manufacturing and Software. See 20 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Singapore, Singapore
- Total investments: 20
- Last investment: Apr 2026
- Lead investor: 80%
- Fund size: $730M
- Last fund: Sep 2015
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/everstonegroup/
- Website: https://www.everstonecapital.com/

Everstone is a VC fund in Singapore focused on Manufacturing and Software. Everstone has a strong partnership oriented culture and truly believes in working closely with entrepreneurs, corporations, asset owners and service providers to achieve mutual success.

## Contacts

5 contacts available for Everstone. Shizune tracks 16 team members at Everstone. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/everstone?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 6 | 30% |
| Software | 4 | 20% |
| Health Care | 3 | 15% |
| Information Technology | 3 | 15% |
| SaaS | 2 | 10% |

47 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 10 | 50% |
| Funding Round | 4 | 20% |
| Series B | 2 | 10% |
| Seed | 1 | 5% |
| Series A | 1 | 5% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 14 | 70% |
| United States | 5 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alok Oberoi | Executive Chairma | 4 | https://shizune.co/investors/profile/alok-oberoi-ff58 |
| Amit Manocha | Managing Director | 2 | https://shizune.co/investors/profile/amit-manocha |
| Atul Kapur | Co-Founder and CIO | 1 | https://shizune.co/investors/profile/atul-kapur-2 |
| Francoise Chung | Executive Director & Head of Fund Administration | 0 | https://shizune.co/investors/profile/francoise-chung |
| Jonathan Fein | Private Equity Vice President | 2 | https://shizune.co/investors/profile/jonathan-fein |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Apothecon Pharmaceuticals | Apothecon Pharmaceuticals is a manufacturing firm that provides formulations, pipelines, and pharmaceutical services. | $270M | Private Equity | Apr 17, 2026 |  |
| Wingify | Wingify's mission is to develop world's best tools for optimizing a website. Their products help you in increasing your website sales conversions, signups and, at the same time, decreasing advertising budget. The products they make are actually pleasing to use and do not require a degree in rocket science. | $148.3M | Venture - Series Unknown | Apr 06, 2026 |  |
| MediaMint | MediaMint is a digital media services firm that works with Publishers, Ad Networks and Agencies to build global operational scale in display, video and mobile advertising |  | Private Equity | Jul 26, 2023 |  |
| Acqueon | Acqueon's conversational engagement software lets customer-centric brands orchestrate campaigns and proactively engage with consumers using voice, messaging, and email channels. Acqueon leverages a rich data platform, statistical and predictive models, and intelligent workflows to let enterprises maximize the potential of every customerconversation. Acqueon is trusted by 200 clients across industries to increase sales, improve collections and re-engage with otherwise-defecting customers. |  | Private Equity | Oct 25, 2022 |  |
| QMetry | The QMetry Digital Quality Platform - Test Automation, Test Management, and Intelligent Quality MetricsQMetry is designed for agile testing and DevOps teams to build, manage, and deploy quality software faster with confidence. To drive digital transformation, enterprises need quality software at reliable speed. QMetry provides the complete agiletesting solution with complete test management, test automation, powerful quality metrics and analytics.QMetry is a suite of products launched by Infostretch with a mission to provide Innovative technology platforms for Agile Digital Enterprises to deploy Quality Software faster with confidence. QMetry brand is trusted by 400+ customers globally across many industries including Finance, Healthcare Services, Travel & Hospitality, Retail, Education and High Technology.QMetry Suite of products include (http://www.qmetry.com/products/)1. QMetry Test Management - Enterprise grade Test Management for Agile Digital organizations 2. QMetry Automation Studio - Test Automation tool for Web, Mobile and Web services 3. QMetry Wisdom - Test Analytics tool to enable intelligent testingQMetry also supports add-ons for its products inside Atlassian JIRA1. QMetry Test Management for JIRA Add-on 2. QMetry Open API for JIRA Add-on 3. QMetry Wisdom for JIRA Add-on QMetry has offices in Santa Clara, CA and New York, NY as well as India. |  | Series A | Aug 27, 2020 |  |
| Infostretch | Infostretch provides solutions and services that help enterprises rapidly launch new mobility and IoT initiatives faster, with less risk & greater success. It leverages a proven combination of technology, processes, ​and expertise to help enterprises accelerate the execution of their digital strategy. They deliver faster and more effectively byunifying expert professional services and best practices with pre-built software frameworks and products. They are built for technical execution at speed across development, testing and integration. It is a digital-first professional services firms built for technical execution at speed – across development, testing, and integration. They also make a measurable difference within days of engagement and equip customers better for the future with streamlined business processes, increased automation, and the right set of tools.Infostretch was founded in 2004 and is headquartered in Santa Clara, California, United States. |  | Private Equity | Aug 18, 2020 |  |
| Slayback Pharma | Slayback is founded on the principle of “connecting the dots”. This principle translates into their philosophy of connecting one idea with another. The idea is to conceptualize and develop complex generic and specialty drugs. They focus on products that are challenging and highly complex to develop and/or manufacture. It could be a complexoil-in-water emulsion or a sterile long acting injectable using nano-spheres or sterile suspensions with complex particle physics. They have also worked on complex hormonal products with challenging cross-contamination issues. They aim to optimize the use of technology and potential (generated from a strong experience in this field) to develop a value proposition for their customers. Through this process of drug development, they remotely aim at reducing the cost of therapy by bringing expensive branded drugs within the reach of patients. | $50M | Series B | Jan 06, 2020 |  |
| Translumina Therapeutics | Translumina Therapeutics is a manufacturing and marketing organization. | $59.5M | Private Equity | Aug 27, 2019 |  |
| Servion Global Solutions | Servion enables business transformation for enterprises in the area of customer experience management (CEM). Servion is a platforms=led systems integrator focused on strengthening customer experience strategies by automating and integrating customer interaction channels. Servion’s IP platforms - ServDesignSM, ServIntuitSM, ServInsightsSM,ServCloudTM and ServCareSM – help enterprises to harness the true value of their CX investments and build effective customer engagement hubs.Over the past two decades, Servion has evolved from being a single channel (voice) interaction expert to being an industry pioneer in omni-channel customer experience. Managing over 10 billion customer interactions annually across 60 countries in 6 continents, Servion empowers enterprises to address both traditional and millennial expectations. | $74M | Private Equity | May 25, 2017 |  |
| OmniActive Health Technologies | OmniActive was born from Kancor Ingredients, an ingredient supplier rooted in the food and flavoring industry. Kancor has decades of experience extracting pure, quality ingredients from whole foods. With a history in extraction of natural products dating back to 1969, we at OmniActive are well versed in the technologies and processes necessary toprovide specialized ingredients to the supplements space, as well as food and beverage companies. | $35M |  | Jan 02, 2017 |  |

10 of 20 investments shown.

## Co-investors
- [Goldman Sachs Merchant Banking Division](https://shizune.co/investors/profile/merchant-banking-division) — VC Fund, 2 deals together
- [Creation Investments Capital Management, LLC](https://shizune.co/investors/profile/creation-investments) — VC Fund, 1 deal together
- [Helion Venture Partners](https://shizune.co/investors/profile/helion-venture-partners) — VC Fund, 1 deal together
- [JM Financial](https://shizune.co/investors/profile/jm-financial) — VC Fund, 1 deal together
- [Recognize Partners](https://shizune.co/investors/profile/recognize-partners) — VC Fund, 1 deal together
- [Waymade Capital](https://shizune.co/investors/profile/waymade-a78d) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Global Founders Capital](https://shizune.co/investors/profile/global-founders-capital) — VC Fund

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [Restaurants VC Funds in India](https://shizune.co/investors/restaurants-vc-funds-india)
- [Hospitality VC Funds in India](https://shizune.co/investors/hospitality-vc-funds-india)
- [Hospitality Investors in India](https://shizune.co/investors/hospitality-investors-india)
- [Restaurants Investors in India](https://shizune.co/investors/restaurants-investors-india)

## FAQ

### What does Everstone invest in?

Everstone invests primarily in Manufacturing, Software and Health Care startups, most often at Private Equity and Funding Round stage. Most of the 20 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Everstone?

Public channels for Everstone include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Everstone?

The team at Everstone includes Alok Oberoi (Executive Chairma), Amit Manocha (Managing Director) and Atul Kapur (Co-Founder and CIO), among 16 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co